- 21297 Foothill Blvd. Ste 203 Hayward, CA 94541-1554
- (408) 290-9440
- (415) 636-9700
- hello@exxceedwellness.com
Many people come in worried about attention or executive function—and discover that the bigger issue is depression: low energy, low drive, poor sleep, and a heavy emotional fog that makes everything harder to do.
If depression has not improved enough with standard treatment, we may discuss Spravato® (esketamine)—an FDA-approved option for treatment-resistant depression—delivered in a certified clinical setting with required monitoring.
Spravato® (esketamine) is a prescription nasal spray used for adults with:
Patients often explore TMS for:
It is provided in a certified medical setting under a required safety program (REMS), with on-site monitoring.
Spravato® may be considered if you:
Eligibility is determined during a clinical evaluation.
We’ll review your symptoms, treatment history, medical history, and current medications to determine safety and fit.
Spravato® is typically part of a broader plan that may include medication management and therapy coordination, based on your needs.
We’ll review risks, precautions, and what to do before/after visits so you feel prepared and supported.
Coverage varies by plan, but Spravato® is often covered when criteria for TRD are met. We can help you understand:
No. It must be administered in a certified clinical setting with monitoring.
Some patients notice changes earlier than with traditional treatments, but response varies. We track progress carefully over time.
We’ll still help you map a next-step plan—whether that’s medication optimization, therapy coordination, TMS, or other evidence-based options.
If you’re wondering whether Spravato® is right for you, start with a conversation. We’ll keep it clear, honest, and pressure-free.
